VISIOPTIC
ActiveSummary
VISIOPTIC has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€30,828) and a net result of -€7,241. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 15% of 21,997 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 29 days late
2025
31-12
Financial
Weakest financial yearnet -€7,241
Net result drops to -€7,241, the lowest in the series.
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
2023
23-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 23 days late
2022
30-05
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
24-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 24 days late
2020
31-12
Financial
Highest result from 2018 to 2025net €18,697 ▲11,797%
Operating result €21,153, net result €18,697, both a record.
30-10
NBB filing
Annual accounts filed
financial year 2019 · micro format · 91 days late
2019
31-12
Financial
Back to profitnet €157
Net result €157 after one loss-making year.
30-09
NBB filing
Annual accounts filed
financial year 2018 · micro format · 61 days late
2018
21-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 21 days late
2017
07-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.